18-23928148-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_198129.4(LAMA3):c.8203C>T(p.Arg2735*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000118 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_198129.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMA3 | NM_198129.4 | c.8203C>T | p.Arg2735* | stop_gained | Exon 63 of 75 | ENST00000313654.14 | NP_937762.2 | |
LAMA3 | NM_000227.6 | c.3376C>T | p.Arg1126* | stop_gained | Exon 26 of 38 | ENST00000269217.11 | NP_000218.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA3 | ENST00000313654.14 | c.8203C>T | p.Arg2735* | stop_gained | Exon 63 of 75 | 1 | NM_198129.4 | ENSP00000324532.8 | ||
LAMA3 | ENST00000269217.11 | c.3376C>T | p.Arg1126* | stop_gained | Exon 26 of 38 | 1 | NM_000227.6 | ENSP00000269217.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251244Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135770
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461346Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727028
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74284
ClinVar
Submissions by phenotype
Junctional epidermolysis bullosa gravis of Herlitz Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg1126*) in the LAMA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA3 are known to be pathogenic (PMID: 10366601, 11810295, 12915477, 16473856, 17362460, 22434185, 23869449, 27827380, 28087116). This variant is present in population databases (rs774133746, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of junctional epidermolysis bullosa (PMID: 22434185). ClinVar contains an entry for this variant (Variation ID: 370076). For these reasons, this variant has been classified as Pathogenic. -
Epidermolysis bullosa, junctional 2B, severe Pathogenic:1
- -
Junctional epidermolysis bullosa Pathogenic:1
Variant summary: LAMA3 c.3376C>T (p.Arg1126X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been observed in the HGMD database. The variant allele was found at a frequency of 2e-05 in 251244 control chromosomes. c.3376C>T has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with Junctional Epidermolysis Bullosa, non-Herlitz (example, Yuen_2012). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at